OVARIAN MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR

Clinical trials for OVARIAN MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR explained in plain language.

Never miss a new study

Get alerted when new OVARIAN MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR trials appear

Sign up with your email to follow new studies for OVARIAN MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for Tough-to-Treat ovarian cancers?

Disease control Ongoing

This study is testing if adding an experimental drug called AZD1775 to a standard chemotherapy (gemcitabine) works better than the chemotherapy alone. It is for women whose ovarian, fallopian tube, or primary peritoneal cancer has returned and stopped responding to platinum-based…

Matched conditions: OVARIAN MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 20, 2026 14:47 UTC

OVARIAN MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR

Get alerted when new OVARIAN MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR trials appear

New hope for Tough-to-Treat ovarian cancers?